Reactivation of insulin-like growth factor binding protein 2 expression in glioblastoma multiforme: a revelation by parallel gene expression profiling.
We carried out a gene expression profiling study using cDNA array technology with 24 primary glioma tissues of low-grade (oligodendroglioma), intermediate-grade (anaplastic oligodendroglioma and anaplastic astrocytoma), and high-grade (glioblastomas multiforme) tumors and found that insulin-like growth factor binding protein 2 (IGFBP2) was consistently overexpressed only in glioblastoma multiforme. The cDNA array results were confirmed by Northern and Western blotting. The fact that the IGFBP2 gene, which is normally expressed in fetal cells and turned off in adult cells, becomes reactivated in the most advanced stage of glioma suggests that glioma progression is a result of dedifferentiation or results from a block of differentiation. Identification of IGFBP2 as a gene associated with glioma progression demonstrates the power and utility of high-throughput gene expression profiling in cancer gene discovery.
Fuller
G N
GN
Department of Pathology, University of Texas M.D. Anderson Cancer Center, Houston 77030, USA.
Rhee
C H
CH
Hess
K R
KR
Caskey
L S
LS
Wang
R
R
Bruner
J M
JM
Yung
W K
WK
Zhang
W
W
D015971:Gene Expression Regulation, Enzymologic; D005909:Glioblastoma / Q000378:metabolism*; D006801:Humans; D018971:Insulin-Like Growth Factor Binding Protein 2 / Q000235:genetics*; D012333:RNA, Messenger / Q000032:analysis
D018971:Insulin-Like Growth Factor Binding Protein 2; D012333:RNA, Messenger